Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shihuida (levamlodipine besylate) real-world study in CKD with hypertension
ChiCTR2000037643Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Levamlodipine in hypertension (HTN) and chronic kidney disease (CKD), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Blood pressure compliance rate, Renal function changes (microalbumin, creatinine, urea) and 2 more. Started Dec 2019; status: recruiting.
02
Drugs
Levamlodipine
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2000037643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037643.